Reagent Kit for Qualitative Detection of IgG Antibodies to SARS-CoV-2 (2019-nCoV IgG (CLIA)) in Human Serum or Plasma Using Automated Immunoassay Systems

Reagent Kit for Qualitative Detection of IgG Antibodies to SARS-CoV-2 (2019-nCoV IgG (CLIA)) in Human Serum or Plasma Using Automated Immunoassay Systems

This reagent kit is designed for the qualitative detection of IgG antibodies against the SARS-CoV-2 coronavirus in human serum or plasma samples using chemiluminescent immunoassay (CLIA) methodology on automated immunoassay analyzers.

Kit Components:

• Reagents necessary for CLIA-based qualitative analysis of IgG antibodies to SARS-CoV-2.
• Calibrators and controls (if applicable).
• Instructions for use.

For in vitro diagnostic use only.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Qualitative Detection of IgG Antibodies to SARS-CoV-2 (2019-nCoV IgG (CLIA)) in Human Serum or Plasma Using Automated Immunoassay Systems, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.